GlassScriptPhysician profile
Ayaz Biviji
NPI 1023008422
$8,214.70
in general payments reported to CMS, 2019-2025
28 companies · $798 in 2025
The $798 reported for 2025 was more than what 85% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,966 · 2020: $562 · 2021: $293 · 2022: $313 · 2023: $1,800 · 2024: $1,483 · 2025: $798.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,302 · Travel and Lodging: $779.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,302.09 |
| Travel and Lodging | $778.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $2,427.91 | 2019 | |
| Stryker Corporation | $1,801.32 | 2019-2025 | Mako, Insignia, Variax |
| Exactech, INC. | $940.10 | 2023 | |
| Smith+Nephew, INC. | $641.20 | 2021-2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Healicoil, Lens 4k |
| Davol INC. | $435.47 | 2020-2024 | Arista Ah Flexitip |
| Depuy Synthes Sales INC. | $384.20 | 2019-2025 | Vapr, Truespan Orthocord, Versalok Orthocord |
| Zimmer Biomet Holdings, INC. | $285.44 | 2019-2024 | Gel-One Cross-Linked Hyaluronate |
| Ethicon US, LLC | $196.21 | 2020-2024 | Dermabond, Dermabond Prineo |
| Miach Orthopaedics, INC. | $142.83 | 2024 | |
| Pacira Therapeutics, INC. | $135.62 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $121.63 | 2024 | Exparel |
| Becton, Dickinson and Company | $113.12 | 2025 | Surgiphor |
| Linvatec Corporation | $92.66 | 2019 | |
| Sanofi-Aventis U.S. LLC | $72.33 | 2019-2022 | |
| Baxter Healthcare | $59.44 | 2025 | Floseal |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $54.55 | 2020 | |
| Heraeus Medical, LLC. | $45.39 | 2021-2022 | |
| Heron Therapeutics, INC. | $40.60 | 2021-2024 | Zynrelef |
| Micromed INC | $36.91 | 2020 | |
| Djo, LLC | $27.01 | 2019-2024 | Procare |
| Convatec INC. | $23.48 | 2020 | |
| Innovation Technologies INC | $23.34 | 2024 | Irrisept |
| Curonix LLC | $22.57 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Novo Nordisk INC | $21.39 | 2020 | |
| Avanos Medical | $20.68 | 2019 | |
| Pfizer INC. | $17.66 | 2019 | |
| Fidia Pharma USA INC. | $16.19 | 2020 | |
| Si-Bone, INC. | $15.45 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ayaz Biviji listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.